The Advanced Robotic Surgery Unit of the Hospital Quirónsalud Tenerife has successfully performed, for the first time in private healthcare in the Canary Islands, a robot-assisted pulmonary lobectomy on a cancer patient who required complete removal of the upper lobe of the left lung.
The Thoracic Surgery team that assisted the patient, made up of Dr. Hernández, Dr. Sánchez and Dr. Bonet, described the intervention as successful, removing the lung tissue affected by the tumor and all the lymph nodes in the chest (lymph node dissection). in a more than reasonable time for an intervention of this magnitude.
Robotic-assisted thoracic surgery is a minimally invasive surgical technique that allows operation through small incisions and adds greater safety and precision to surgery. In addition to providing an increased three-dimensional view and facilitating access to complex anatomical areas, the Da Vinci platform completely eliminates the involuntary tremor that the surgeon may have during the intervention.
The specialist remains in the operating room at all times and handles the instruments from a console that transmits the movements of his hands to the robotic arms. On the operating table, he is assisted by another surgeon and nurses specially trained in robotic surgery.
“Due to the location of the tumor, this patient required a complete lobectomy of the upper lobe of the left lung. The Da Vinci robotic system is the best and most modern option both for this type of surgery and for the most complex urological or gynecological operations”, explains the medical director of Quirónsalud Tenerife, Dr. Óscar Blasco, who pointed out that after three hours intervention, the patient was discharged after three days, to then complete her recovery at home.
Quirónsalud is the leading hospital group in Spain and, together with its parent company Fresenius-Helios, also in Europe. In addition to its activity in Spain, Quirónsalud is also present in Latin America, particularly in Colombia and Peru. Together, it has more than 45,000 professionals in more than 160 health centers, including 55 hospitals with approximately 8,000 hospital beds. It has the most advanced technology and a great team of highly specialized professionals of international prestige. Its centers include the Fundación Jiménez Díaz University Hospital, Teknon Medical Center, Ruber Internacional, Quirónsalud Madrid University Hospital, Quirónsalud Barcelona Hospital, Dexeus University Hospital, Gipuzkoa Polyclinic, General University Hospital of Catalonia, Quirónsalud Sagrado Corazón Hospital, etc.
The Group works to promote teaching (nine of its hospitals are university hospitals) and medical-scientific research (it has the FJD Health Research Institute, accredited by the Secretary of State for Research, Development and Innovation).
Likewise, its care service is organized into transversal units and networks that allow optimization of the experience accumulated in the different centers and the clinical translation of its research. Currently, Quirónsalud is developing a multitude of research projects throughout Spain and many of its centers carry out cutting-edge work in this field, being pioneers in different specialties such as oncology, cardiology, endocrinology, gynecology and neurology, among others.